Abstract:Cardiac disorders in cancer patients pose significant challenges to disease prognosis. While it has been established that these disorders are linked to cancer cells, the precise underlying mechanisms remain elusive. In this study, we investigated the impact of cancerous ascites from the rat colonic carcinoma cell line RCN9 on H9c2 cardiomyoblast cells. We found that the ascites reduced mitochondrial volume, increased oxidative stress, and decreased membrane potential in the cardiomyoblast cells, leading to apoptosis and autophagy. Although the ascites fluid contained a substantial amount of high-mobility group box-1 (HMGB1), we observed that neutralizing HMGB1 with a specific antibody mitigated the damage inflicted on myocardial cells. Our mechanistic investigations revealed that HMGB1 activated both nuclear factor κB and phosphoinositide 3-kinases-AKT signals through HMGB1 receptors, namely the receptor for advanced glycation end products and toll-like receptor-4, thereby promoting apoptosis and autophagy. In contrast, treatment with berberine (BBR) induced the expression of miR-181c-5p and miR-340-5p while suppressing HMGB1 expression in RCN9 cells. Furthermore, BBR reduced HMGB1 receptor expression in cardiomyocytes, consequently mitigating HMGB1-induced damage. We validated the myocardial protective effects of BBR in a cachectic rat model. These findings underscore the strong association between HMGB1 and cancer cachexia, highlighting BBR as a promising therapeutic agent for myocardial protection through HMGB1 suppression and modulation of the signaling system.

What problem does this paper attempt to address?

The problem this paper attempts to address is myocardial injury in cancer patients. Specifically, the study focuses on how high mobility group box 1 (HMGB1) secreted by colorectal cancer (CRC) cells leads to autophagy and apoptosis in myocardial cells, thereby causing myocardial injury. Additionally, the study explores the role of berberine (BBR) in inhibiting HMGB1 expression and its signaling pathways to alleviate cancer-induced myocardial injury. ### Main Issues: 1. **Mechanism of cancer-related myocardial injury**: The study aims to elucidate how HMGB1 secreted by colorectal cancer cells causes myocardial injury by activating autophagy and apoptosis pathways in myocardial cells. 2. **Protective role of berberine**: The study investigates whether berberine can protect myocardial cells from cancer-induced injury by inhibiting HMGB1 expression and signaling. ### Research Background: - **Cancer cachexia**: Approximately 40-80% of patients with advanced cancer develop cachexia, with 20-30% of deaths related to cachexia. Myocardial injury is a significant manifestation of cancer cachexia, but its specific mechanisms remain unclear. - **Role of HMGB1**: HMGB1 is a protein secreted by cancer cells that binds to receptors on the surface of myocardial cells (such as RAGE and TLR4), activating NF-κB and PI3K-AKT signaling pathways, leading to autophagy and apoptosis in myocardial cells. - **Potential of berberine**: Berberine is a plant alkaloid with anti-inflammatory and anti-cancer properties. It may alleviate myocardial injury by upregulating miRNAs such as miR-181c-5p and miR-340-5p to inhibit HMGB1 expression. ### Research Methods: - **In vitro experiments**: Using the RCN9 colorectal cancer cell line and H9c2 myocardial cell line, cancerous ascites were added to the culture medium to simulate a cachexia environment, observing changes in autophagy, apoptosis, and mitochondrial function in myocardial cells. - **In vivo experiments**: In a rat model, cachexia was induced by intraperitoneal injection of RCN9 cells, and the protective effect of berberine on myocardial injury was observed. - **Molecular mechanism study**: Techniques such as Western Blot, ELISA, and fluorescence staining were used to detect changes in HMGB1 and its signaling pathways, verifying the mechanism of berberine's action. ### Research Results: - **Pathogenic role of HMGB1**: Cancerous ascites contain a large amount of HMGB1, which significantly increases autophagy and apoptosis in myocardial cells, reducing mitochondrial volume and membrane potential. - **Protective role of berberine**: Berberine can inhibit HMGB1 expression and reduce the expression of HMGB1 receptors, thereby alleviating damage to myocardial cells. In the rat model, berberine not only reduced tumor growth and ascites volume but also restored myocardial weight and maturity, and decreased levels of myocardial injury markers. ### Conclusion: This study reveals the key role of HMGB1 in cancer-related myocardial injury and demonstrates that berberine has a significant myocardial protective effect by inhibiting HMGB1 expression and signaling. These findings provide a theoretical basis for developing new therapies for cancer cachexia-induced myocardial injury.

Berberine Improves Cancer-Derived Myocardial Impairment in Experimental Cachexia Models by Targeting High-Mobility Group Box-1

Berbamine Exhibits Potent Antitumor Effects on Imatinib-Resistant CML Cells in Vitro and in Vivo

Berberine inhibits excessive autophagy and protects myocardium against ischemia/reperfusion injury via the RhoE/AMPK pathway

Berberine plays a cardioprotective role by inhibiting macrophage Wnt5a/β‐catenin pathway in the myocardium of mice after myocardial infarction

Berberine Ameliorates Diabetic Cardiomyopathy in Mice by Decreasing Cardiomyocyte Apoptosis and Oxidative Stress

Berberine Promotes Cardiac Function by Upregulating PINK1/Parkin-Mediated Mitophagy in Heart Failure.

The small molecule ACM-001 improves cardiac function in a rat model of severe cancer cachexia

Berberine Hydrochloride Protects Cytokine-Induced Inflammation through Multiple Pathways

Berberine improves pressure overload-induced cardiac hypertrophy and dysfunction through enhanced autophagy.

Berberine Attenuates Adverse Left Ventricular Remodeling and Cardiac Dysfunction after Acute Myocardial Infarction in Rats: Role of Autophagy

Berberine ameliorates chronic intermittent hypoxia‐induced cardiac remodelling by preserving mitochondrial function, role of SIRT6 signalling

Small-molecule mediated MuRF1 inhibition protects from doxorubicin-induced cardiac atrophy and contractile dysfunction

Caprylic Acid Inhibits High Mobility Group Box-1-Induced Mitochondrial Damage in Myocardial Tubes

Berberine up-regulates miR-340-5p to protect myocardial ischaemia/reperfusion from HMGB1-mediated inflammatory injury

Reversal of muscle atrophy by Zhimu and Huangbai herb pair via activation of IGF-1/Akt and autophagy signal in cancer cachexia

Berberine inhibits cardiac remodeling of heart failure after myocardial infarction by reducing myocardial cell apoptosis in rats

Berberine alleviates cardiac ischemia/reperfusion injury by inhibiting excessive autophagy in cardiomyocytes

Berberine Induces Combined Cell Death in Gastrointestinal Cell Lines

Bcl-xL is required for the protective effects of low-dose berberine against doxorubicin-induced cardiotoxicity through blocking apoptosis and activating mitophagy-mediated ROS elimination

BNIP3 Downregulation Ameliorates Muscle Atrophy in Cancer Cachexia

Brassinin alleviates cancer cachexia by suppressing diverse inflammatory mechanisms in mice